Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial.
Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population.
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group.
Mitoxantrone - an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis.
Episode 29 with Dr. Monica Carson on MS research funding
215ON201 BIIB033 In Acute Optic Neuritis (AON) (RENEW)
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.
Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients.
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion.
Teva announces U.S. FDA approval of three-times-a-week COPAXONE® (glatiramer acetate injection) 40mg/mL
29th European Committee for Treatment and Research in Multiple Sclerosis Congress
Glial Biology: Functional Interactions Among Glia & Neurons (Gordon Research Seminar)
A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.
XI European Meeting on Glia Cells in Health and Disease
Estrogen and testosterone therapies in multiple sclerosis.
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
Breastfeeding is not related to postpartum relapses in multiple sclerosis.
Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
Understanding the Metabolic Consequences of Human Arylsulfatase A Deficiency through a Computational Systems Biology Study.
NYSCF Webinar Series: Multiple Sclerosis and the Promise of Stem Cell Research
Episode 32 with Dr. David Holtzman on the connection between MS and Alzheimer 's disease
Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.

Pages